Recommended Pages at ophthalmologytimes.modernmedicine.com
Endophthalmitis tied to repackaged bevacizumab - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “Use of repackaged intravitreal injections of bevacizumab (Avastin, Genentech) has caused a cluster of serious eye infections in the Miami area, according to the FDA.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on September 8, 2011 at 1:19 am By:
Debbie Liebross Health Social Media
FDA reports repackaged intravitreal injections has caused cluster of serious eye infections in Miami http://t.co/MPuB295 #eye health
B+L supports Japan - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “Bausch + Lomb is activating a relief support plan in response to the earthquake and tsunami disaster affecting Japan.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 23, 2011 at 8:42 pm By:
TheLASIKDoc Ophthalmologist, Physician, Doctor, and Surgeon
B+L supports Japan - - Ophthalmology Times http://chilp.it/c6d220 Bravo B&L!!
Alcon receives approval for toric IOL; affiliate signs 5-year contract with LCA - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “Alcon announced in a prepared statement that the FDA has approved its aspheric toric IOL (AcrySof).” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 20, 2009 at 8:45 am By:
Ophthalmology Times Ophthalmology and Health Magazine
Alcon receives approval for toric IOL; affiliate signs 5-year contract with LCA. http://ow.ly/18ym
Bausch & Lomb, Santen enter into agreement for IOL development - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “Bausch & Lomb and Santen Pharmaceutical Co. have entered into a licensing agreement for the development of certain IOL materials, according to statements issued by the companies. Financial terms will not be disclosed.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 20, 2009 at 5:30 am By:
Ophthalmology Times Ophthalmology and Health Magazine
Bausch & Lomb, Santen enter into agreement for IOL development. http://ow.ly/18y6
Government restriction is lifted for stem cell research funding - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “President Barack Obama has signed an order to lift restrictions on federal funding for embryonic stem cell research, according to a prepared statement.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 20, 2009 at 2:30 am By:
Ophthalmology Times Ophthalmology and Health Magazine
US government restriction on stem cell research funding is lifted. http://ow.ly/18xW
ThromboGenics completes enrollment for MIVI II DME trial - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “ThromboGenics has completed patient enrollment for a phase II trial of microplasmin intravitreal injection for the treatment of diabetic macular edema, according to a statement issued by the company.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 19, 2009 at 11:25 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
ThromboGenics completes enrollment for MIVI II DME trial. http://ow.ly/18wt
Aton acquires U.S. marketing rights for timolol - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “Aton Pharma Inc. has acquired the U.S. marketing rights to the timolol (Timoptic) product line from Merck & Co. Inc.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 7, 2009 at 12:15 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
Aton acquires U.S. marketing rights for timolol. http://ow.ly/Gde
Visiogen forms European subsidiary, releases accommodating IOL - - Ophthalmology Times
ophthalmologytimes.modernmedicine.com — “During the winter meeting of the European Society of Cataract and Refractive Surgeons, held in early February here, Visiogen Inc. announced the formation of its European subsidiary, Visiogen Europe.” View full resource at ophthalmologytimes.modernmedicine.com
Most Recently Shared on March 6, 2009 at 5:15 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
Visiogen forms European subsidiary, releases accommodating IOL. http://ow.ly/GcU
